Dasatinib monohydrate is a hydrate form of dasatinib, a tyrosine kinase inhibitor used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It contains dasatinib (anhydrous) and one molecule of water of crystallization.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 863127-77-9
Dasatinib
pharmaceutical raw material
N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(4-nitrosopiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
research compound
Dasatinib N-Oxide
pharmaceutical raw material
Dasatinib Impurity 47
pharmaceutical intermediate
CJC-1295
pharmaceutical raw material
Cefodizime sodium
pharmaceutical raw material
Medetomidine
pharmaceutical raw material
Medetomidine hydrochloride
pharmaceutical raw material
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;hydrate
XHXFZZNHDVTMLI-UHFFFAOYSA-N
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO.O